T. Rowe Price Associates’s Aceragen Inc ACGN Stock Holding History

T. Rowe Price Associates’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,556	Closed	-$62K	–	3061
2021 Q3	$62K	Hold	3,556	–	–	﹤0.01%	2898
2021 Q2	$72K	Buy	3,556 +2,596	+270%	+$52.3K	﹤0.01%	2875
2021 Q1	$21K	Hold	960	–	–	﹤0.01%	2838
2020 Q4	$60K	Buy	960 +359	+60%	+$20.6K	﹤0.01%	2644
2020 Q3	$22K	Hold	601	–	–	﹤0.01%	2580
2020 Q2	$18K	Hold	601	–	–	﹤0.01%	2488
2020 Q1	$13K	Hold	601	–	–	﹤0.01%	2496
2019 Q4	$19K	Hold	601	–	–	﹤0.01%	2513
2019 Q3	$29K	Hold	601	–	–	﹤0.01%	2504
2019 Q2	$27K	Sell	601 -14	-2%	-$662	﹤0.01%	2529
2019 Q1	$27K	Hold	615	–	–	﹤0.01%	2521
2018 Q4	$29K	Buy	+615	New	+$70.7K	﹤0.01%	2541
2018 Q3	–	Sell	-288	Closed	-$52K	–	2616
2018 Q2	$52K	Sell	288 -316	-52%	-$73.7K	﹤0.01%	2563
2018 Q1	$151K	Buy	604 +324	+116%	+$88.9K	﹤0.01%	2454
2017 Q4	$80K	Buy	+280	New	+$80K	﹤0.01%	2527

Other funds holding ACGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates's ACGN Position: Q4 2021 in Review

T. Rowe Price Associates sold out of Aceragen Inc (ACGN) in Q4 2021, closing a stake of 3,556 shares — an estimated $62K sold.

T. Rowe Price Associates first reported a position in ACGN in Q4 2017 and held it in 15 quarters. The position peaked at $151K in Q1 2018. 34 funds tracked by Wall St. Rank hold ACGN as of Q4 2021.

T. Rowe Price Associates reported no remaining Aceragen Inc position as of Q4 2021 after selling out during the quarter.
T. Rowe Price Associates sold 3,556 Aceragen Inc shares in Q4 2021, an estimated $62K.
T. Rowe Price Associates first reported a position in Aceragen Inc in Q4 2017 and held it in 15 quarters.
T. Rowe Price Associates's Aceragen Inc position peaked at $151K in Q1 2018.
34 funds tracked by Wall St. Rank held Aceragen Inc as of Q4 2021.

Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.